BNTC
Benitec Biopharma Inc.
$16.36
+$0.19(+1.18%)
61
Overall
60
Value
63
Tech
--
Quality
Market Cap
$424.47M
Volume
73.76K
52W Range
$9.10 - $17.15
Target Price
$24.86
Order:
Income Statement
| Metric | Trend | Chart | 2018 Jun | 2019 Jun | 2020 Jun | 2021 Jun | 2022 Jun | 2023 Jun | 2024 Jun |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $315.0K | $16.2M | $97.0K | $59.0K | $73.0K | $75.0K | -- | ||
| Total Revenue | $378.0K | $16.2M | $102.0K | $59.0K | $73.0K | $75.0K | -- | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | -- | -- | -- | -- | $9.0K | -- | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $315.0K | $16.2M | $102.0K | $59.0K | $64.0K | $75.0K | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $15.5M | $13.5M | $8.4M | $13.7M | $17.9M | $19.2M | $22.5M | ||
| Research & Development | $6.9M | $3.1M | $3.0M | $7.0M | $11.3M | $12.8M | $15.6M | ||
| Research Expense | $6.9M | $3.1M | $3.0M | $7.0M | $11.3M | $12.8M | $15.6M | ||
| Selling, General & Administrative | $1.1M | $1.7M | $5.6M | $6.5M | $6.6M | $6.4M | $7.0M | ||
| Selling & Marketing Expenses | $468.0K | $1.0M | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $587.0K | $648.0K | $5.6M | $6.5M | $6.6M | $6.4M | $7.0M | ||
| Salaries & Wages | $5.5M | $6.0M | -- | -- | $-34.0K | -- | -- | ||
| Depreciation & Amortization | $194.0K | $221.0K | $190.0K | $231.0K | $167.0K | $136.0K | $87.0K | ||
| Depreciation & Amortization | $194.0K | $221.0K | $190.0K | $231.0K | $167.0K | $136.0K | $87.0K | ||
| Amortization | -- | -- | $184.0K | $193.0K | $225.0K | $245.0K | $256.0K | ||
| Other Operating Expenses | $1.9M | $2.6M | $185.0K | $-123.0K | $-9.0K | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $-15.2M | $2.6M | $-8.3M | $-13.6M | $-17.9M | $-19.1M | $-22.5M | ||
| EBITDA | $-11.4M | $4.3M | $-8.3M | $-13.2M | $-17.8M | $-19.2M | $-21.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $32.0K | $33.0K | -- | ||
| Intinc | $242.0K | $170.0K | $62.0K | $-6.0K | $-32.0K | $-33.0K | $904.0K | ||
| Net Non-Operating Interest Income/Expense | $242.0K | $170.0K | $62.0K | $-6.0K | $-32.0K | $-33.0K | $904.0K | ||
| Gain on Sale of Securities | -- | -- | $-1.0K | $16.0K | $-11.0K | $-3.0K | $-1.0K | ||
| Other Income/Expense | $-3.3M | $-1.2M | $-38.0K | $-53.0K | $-322.0K | $33.0K | $205.0K | ||
| Other Special Charges | $4.1M | $1.4M | $39.0K | $37.0K | $-79.0K | $-30.0K | $-204.0K | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-11.6M | $4.1M | $-8.6M | $-13.6M | $-18.2M | $-19.6M | $-21.8M | ||
| Pre-Tax Income | $-11.6M | $4.1M | $-8.6M | $-13.6M | $-18.2M | $-19.6M | $-22.5M | ||
| NET INCOME | |||||||||
| Net Income | $-11.7M | $4.0M | $-8.3M | $-13.9M | $-18.2M | $-19.6M | $-21.8M | ||
| Net Income (Continuing Operations) | $-11.7M | $4.0M | $-8.3M | $-13.9M | $-18.2M | $-19.6M | $-21.8M | ||
| Net Income (Discontinued Operations) | $-11.7M | $4.0M | $-8.3M | $-13.9M | $-18.2M | $-19.6M | $-21.8M | ||
| Net Income (Common Stockholders) | $-11.7M | $4.0M | $-8.3M | $-13.9M | $-18.2M | $-19.6M | $-22.4M | ||
| Normalized Income | -- | -- | -- | $-10.8M | $-14.4M | -- | $-21.6M | ||
| TOTALS | |||||||||
| Total Expenses | $15.5M | $13.5M | $8.4M | $13.7M | $17.9M | $19.2M | $22.5M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $210.5M | $257.0M | $60.1K | $252.7K | $480.7K | $1.4M | $4.1M | ||
| Average Shares Outstanding (Diluted) | $194.4M | $200.3M | $60.1K | -- | $480.7K | $1.4M | $4.1M | ||
| Shares Outstanding | $257.0M | $257.0M | $1.1M | $480.7K | $480.7K | $2.5M | $10.6M | ||
| Basic EPS | $-0.06 | $0.02 | $-137.7 | $-54.91 | $-37.91 | $-14.12 | $-5.51 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-137.7 | $-54.91 | $-37.91 | $-14.12 | $-5.51 | ||
| Diluted EPS | $-0.06 | $0.02 | $-137.7 | $-54.91 | $-37.91 | $-14.12 | $-5.51 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-37.91 | $-14.12 | $-5.51 | ||
| OTHER METRICS | |||||||||
| Commission Expenses | -- | $662.0K | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $-1.0K | $-9.0K | -- | -- | -- | -- | -- | ||
| Other Gand A | $587.0K | $648.0K | $5.6M | $6.5M | $6.6M | $6.4M | $7.0M | ||
| Other Write Down | $783.0K | -- | -- | -- | -- | -- | -- | ||
| Realized Capital Gain | $-63.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $587.0K | $648.0K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTC | $16.36 | +1.2% | 73.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |